In a report released today, Jamie Perse from Goldman Sachs maintained a Hold rating on Lifestance Health Group (LFST – Research Report), with a price target of $8.00. The company’s shares opened today at $6.28.
According to TipRanks, Perse is an analyst with an average return of -7.8% and a 34.78% success rate. Perse covers the Healthcare sector, focusing on stocks such as Agilon Health, Option Care Health, and Tenet Healthcare.
In addition to Goldman Sachs, Lifestance Health Group also received a Hold from J.P. Morgan’s Lisa Gill in a report issued on November 9. However, yesterday, Cowen & Co. maintained a Buy rating on Lifestance Health Group (NASDAQ: LFST).
See today’s best-performing stocks on TipRanks >>
Based on Lifestance Health Group’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $217.56 million and a GAAP net loss of $37.85 million. In comparison, last year the company earned a revenue of $173.84 million and had a GAAP net loss of $120.45 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
LifeStance Health Group Inc is a providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. The company delivers personalized, data-driven and comprehensive care to help patients stay healthy and employs over 3,300 psychiatrists, advanced practice nurses, psychologists and therapists.
Read More on LFST:
